Tekeli Taşkömür, A., Erten, Özlem, & Dilbaz, B. (2021). Comparison of two drospirenone-containing oral contraceptives for their effect on the ovary, menstrual cycle, acne, and side-effect profile: 20 µg ethinylestradiol/3 mg drospirenone (24/4) versus 30 µg ethinylestradiol/3 mg drospirenone (21/7). Journal of Surgery and Medicine, 5(11), 1099–1103. https://doi.org/10.28982/josam.1002126